Key result
Higher pan-immune-inflammation value linked to ~15% greater high vascular burden in carotid stenting.
Why the study?
Is the Pan-immune-inflammation value (PIV) associated with vascular comorbidity burden in patients undergoing carotid artery stenting?
Observational (n=221)
Is the Pan-immune-inflammation value (PIV) associated with vascular comorbidity burden in patients undergoing carotid artery stenting?
Odds Ratio: 1.152 (95% CI 1.058–1.255)
p-value: p=0.001
Higher Pan-immune-inflammation value is independently associated with greater vascular comorbidity burden in patients undergoing carotid artery stenting, though its limited discriminative ability precludes its use as a standalone risk tool.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kunak et al. (2026) conducted an observational in Carotid artery stenting (n=221). Pan-immune-inflammation value (PIV) vs. Lower PIV was evaluated on High vascular burden (score 3-5) (OR 1.152, 95% CI 1.058-1.255, p=0.001). Every 100-unit increase in pan-immune-inflammation value was independently associated with high vascular burden in patients undergoing carotid artery stenting (OR 1.152; 95% CI 1.058-1.255; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: